Literature DB >> 26221943

Enhanced tumor-targeted gene delivery by bioreducible polyethylenimine tethering EGFR divalent ligands.

Duhwan Lee1, Yeong Mi Lee, Jihoon Kim, Myung Kyu Lee, Won Jong Kim.   

Abstract

This work demonstrates successful delivery of a gene to EGFR-overexpressed cancer cells by using a rationally designed branched GE11 peptide as a targeting ligand. In addition, we exploited the effect of the divalent structure of the branched GE11 peptide on the gene delivery and tumor targeting efficiency, compared to the monovalent GE11 peptide. The GE11 or branched GE11-tethered polymers were successfully synthesized. They are composed of a targeting peptide, disulfide crosslinked low molecular weight polyethylenimine and polyethylene glycol. Here, we evaluated the physicochemical properties, cytotoxicity and in vitro transfection efficiency and in vivo biodistribution of the GE11 and branched GE11 tethered polyplexes. Our results demonstrated that GE11 and bGE11-tethered gene delivery carriers showed efficient gene condensing ability, an enhanced transfection efficiency and targeting ability with low cytotoxicity. Interestingly, the branched GE11-tethered polymer showed the greater targeting ability to EGFR-overexpressed cancer cells in vivo than the GE11-tethered polymer. Therefore, this branched structure of targeting ligand has the potential for providing a novel strategy to design an efficient targeted delivery system.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26221943     DOI: 10.1039/c5bm00004a

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  3 in total

1.  EGFR-targeted pemetrexed therapy of malignant pleural mesothelioma.

Authors:  Liang Yang; Hanghang Fang; Jingjing Jiang; Yongjie Sha; Zhiyuan Zhong; Fenghua Meng
Journal:  Drug Deliv Transl Res       Date:  2021-11-20       Impact factor: 5.671

2.  Remission of lymphoblastic leukaemia in an intravascular fluidic environment by pliable drug carrier with a sliding target ligand.

Authors:  Donghyun Jang; Yeong Mi Lee; Jaehyun Lee; Junsang Doh; Won Jong Kim
Journal:  Sci Rep       Date:  2017-01-17       Impact factor: 4.379

3.  Antibody-targeted chromatin enables effective intracellular delivery and functionality of CRISPR/Cas9 expression plasmids.

Authors:  Tobias Killian; Annette Buntz; Teresa Herlet; Heike Seul; Olaf Mundigl; Gernot Längst; Ulrich Brinkmann
Journal:  Nucleic Acids Res       Date:  2019-06-04       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.